Filing Details
- Accession Number:
- 0000899243-22-008109
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-28 17:18:06
- Reporting Period:
- 2022-02-24
- Accepted Time:
- 2022-02-28 17:18:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-02-24 | 6,038 | $227.86 | 43,649 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2022-02-25 | 1,040 | $229.41 | 42,609 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-25 | 3,188 | $230.62 | 39,421 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-25 | 2,784 | $231.64 | 36,637 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-25 | 560 | $232.68 | 36,077 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $229.41 (range $228.91 to $229.81).
- Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $230.62 (range $230.07 to $231.05).
- Open market sales reported on this line occurred at a weighted average price of $231.64 (range $231.08 to $232.07).
- Open market sales reported on this line occurred at a weighted average price of $232.68 (range $232.43 to $232.87).
Billionaire Hedge Funds
